Matthew Shawn Morris - Nov 3, 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
Chief Executive Officer, Director
Signature
/s/ Thomas Bartrum, as attorney-in-fact
Stock symbol
PRVA
Transactions as of
Nov 3, 2022
Transactions value $
-$928,592
Form type
4
Date filed
11/7/2022, 03:12 PM
Previous filing
Oct 17, 2022
Next filing
Nov 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, $0.01 par value per share Options Exercise $31.3K +15.6K +12.83% $2.00 137K Nov 3, 2022 Direct
transaction PRVA Common Stock, $0.01 par value per share Sale -$391K -12.8K -9.34% $30.45 125K Nov 3, 2022 Direct F1, F2
transaction PRVA Common Stock, $0.01 par value per share Sale -$87.1K -2.8K -2.25% $31.10 122K Nov 3, 2022 Direct F1, F3
transaction PRVA Common Stock, $0.01 par value per share Options Exercise $31.3K +15.6K +12.83% $2.00 137K Nov 4, 2022 Direct
transaction PRVA Common Stock, $0.01 par value per share Sale -$345K -12K -8.77% $28.68 125K Nov 4, 2022 Direct F1, F4
transaction PRVA Common Stock, $0.01 par value per share Sale -$106K -3.58K -2.86% $29.48 122K Nov 4, 2022 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVA Stock Option (Right to Purchase) Options Exercise -$31.3K -15.6K -0.34% $2.00 4.53M Nov 3, 2022 Common Stock 15.6K $2.00 Direct F6
transaction PRVA Stock Option (Right to Purchase) Options Exercise -$31.3K -15.6K -0.34% $2.00 4.51M Nov 4, 2022 Common Stock 15.6K $2.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.92 to $30.90 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.93 to $31.44 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.26 to $29.25 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.28 to $29.72 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F6 All of the stock options are fully vested and exercisable.